The Human Papillomavirus can be transmitted through skin-to-skin contact or through sexual activity.
Although HPV often goes away on its own, certain types can cause medical concerns, from genital warts to cervical cancer.
Human papillomavirus (HPV) infection is the main cause of invasive cervical cancer (ICC) in women, and an important cause of vaginal, vulvar and anal cancer in women as well as anal and penile cancer in men.
Kenya has a population of 16.2 million women ages 15 years and older who are at risk of developing cervical cancer. Current estimates indicate that every year 5236 women are diagnosed with cervical cancer and 3211 die from the disease. Cervical cancer ranks as the 2nd most frequent cancer among women in Kenya and the 2nd most frequent cancer among women between 15 and 44 years of age. About 9.1% of women in the general population are estimated to harbor cervical HPV-16/18 infection at a given time, and 63.1% of invasive cervical cancers are attributed to HPVs 16 or 18.
The HPV vaccine is a safe and effective vaccine that can protect children and adults from HPV-related diseases.
The Kenyan Government, global experts and the United States Centers for Disease Control and Prevention (CDC) recommends that preteens receive the vaccine at around age 11 or 12 years old. This ensures that they’re protected against HPV before they’re likely to have exposure to the virus. You can get the vaccine until age 45.